Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Axcella Health Inc.AXLA · Entity 116059 | Director | May 20, 2021 | May 24, 2021 |
| Moderna, Inc.MRNA · Entity 2025 | President | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Axcella Health Inc.
Report date May 20, 2021 · Filed May 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.24 · Expires 2031-05-19 | Direct | 20,000 |
Reported balance
After 2021-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-05-20 · Grant · Acquired 20,000 · Balance 20,000 F1: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting.
Moderna, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,562,029 |
Ending reported balance
After 2026-09-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-14 · Exercise / conversion · Acquired 76,453 · Balance 1,566,152 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. Row 2 · 2026-09-14 · Sale · Disposed 40,294 · Balance 1,525,858 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.99 to $144.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Row 3 · 2026-09-15 · Exercise / conversion · Acquired 76,452 · Balance 1,602,310 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. Row 4 · 2026-09-15 · Sale · Disposed 40,281 · Balance 1,562,029 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.97 to $146.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.21 · Expires 2027-02-23 | Direct | 382,262 |
Reported balance
After 2026-09-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-14 · Exercise / conversion · Disposed 76,453 · Balance 382,262 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. F5: This option is fully vested and exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.21 · Expires 2027-02-23 | Direct | 305,810 |
Reported balance
After 2026-09-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-15 · Exercise / conversion · Disposed 76,452 · Balance 305,810 F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026. F5: This option is fully vested and exercisable. |
| Common StockSEC Table I · non-derivative | IndirectBy Valhalla, LLC | 4,116 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 4,116 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 151,933 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 151,933 F4: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.99 to $144.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.97 to $146.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F5: This option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 21:14 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-26-000042 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,458,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:14 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 316 | $51.71 | $16,340.36 |
DisclosureSEC source: 0001682852-26-000042 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,457,763 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:14 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-26-000042 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,458,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionStock Option (Right to Buy) · Derivative | 48,330 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001682852-26-000036 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,330 Underlying: Common Stock · 48,330 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionStock Option (Right to Buy) · Derivative | 111,679 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001682852-26-000036 · form4.xml · derivative · entry 6 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,678 Underlying: Common Stock · 111,679 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | SaleCommon Stock | 160,009 | $48.84 | $7,814,839.56 |
DisclosureSEC source: 0001682852-26-000036 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,457,427 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 48,330 | $19.15 | $925,519.50 |
DisclosureSEC source: 0001682852-26-000036 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,617,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:49 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 111,679 | $19.15 | $2,138,652.85 |
DisclosureSEC source: 0001682852-26-000036 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,569,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:33 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 2,362 | $41.99 | $99,180.38 |
DisclosureSEC source: 0001682852-26-000019 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,457,427 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:33 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantCommon Stock | 4,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-26-000019 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,459,789 F1 · kind: The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs"). Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 652 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000084 · form4.xml · derivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652 Underlying: Common Stock · 652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 316 | $25.98 | $8,209.68 |
DisclosureSEC source: 0001682852-25-000084 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,905 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:44 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000084 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,455,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · derivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,053 Underlying: Common Stock · 610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 295 | $25.01 | $7,377.95 |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,569 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,931 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 695 | $24.75 | $17,201.25 |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,254 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:19 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000078 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,454,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 29, 2025 Filed Sep 2, 2025 21:20 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001682852-25-000048 · form4.xml · derivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,304 Underlying: Common Stock · 651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 29, 2025 Filed Sep 2, 2025 21:20 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 315 | $24.47 | $7,708.05 |
DisclosureSEC source: 0001682852-25-000048 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453,512 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| August 29, 2025 Filed Sep 2, 2025 21:20 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 651 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682852-25-000048 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 611 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · derivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,663 Underlying: Common Stock · 611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 296 | $25.10 | $7,429.60 |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453,176 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,368 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 695 | $24.73 | $17,187.35 |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,861 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| August 27, 2025 Filed Aug 29, 2025 20:06 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021026 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,453,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 652 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016212 · form4.xml · derivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,955 Underlying: Common Stock · 652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 316 | $26.93 | $8,509.88 |
DisclosureSEC source: 0001127602-25-016212 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,119 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 20:36 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016212 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · derivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,274 Underlying: Common Stock · 610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 295 | $26.76 | $7,894.20 |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,451,783 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 1,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,805 Underlying: Common Stock · 1,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 695 | $26.26 | $18,250.70 |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,451,468 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:09 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 1,436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-015904 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 148,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · derivative · entry 10 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,524 Underlying: Common Stock · 148,524 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F7 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 238,043 | $0.00 Strike: $30.96 | $0.00 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · derivative · entry 9 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,043 Underlying: Common Stock · 238,043 shares Expires 2035-03-01 F6 · derivative.exercise_date: 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 611 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · derivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,884 Underlying: Common Stock · 611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 652 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,607 Underlying: Common Stock · 652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 296 | $31.09 | $9,202.64 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450,727 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,451,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 316 | $31.09 | $9,824.44 |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450,412 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:41 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007545 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:21 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionRestricted Stock Units · Derivative | 5,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007252 · form4.xml · derivative · entry 5 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,241 Underlying: Common Stock · 5,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:21 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 2,779 | $33.58 | $93,318.82 |
DisclosureSEC source: 0001127602-25-007252 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450,076 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:21 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 5,746 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007252 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,452,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:12 UTC | Moderna, Inc. MRNA · Entity 2025 | Tax withholdingCommon Stock | 2,771 | $30.93 | $85,707.03 |
DisclosureSEC source: 0001127602-25-004900 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,447,109 F2 · kind: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2022 PSUs. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:12 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantCommon Stock | 5,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004900 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,449,880 F1 · kind: The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 1, 2022 (the "2022 PSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.